HOW TRAMADOL WORKS TO FIGHT AGAINST THE PAIN
Pharmacology is one of the scientific areas that are involved in the drug discovery process. Its team of professionals is the one who check drug substances for physiological test because there is a difference between what substances do and how they act.
The increase in chemical information has been the development of the modern pharmaceutical industry. The science of pharmacy appeared gradually from the conventional empiricism of the herbalist, but by 19th century there had been some important accomplishments in the study of existing drugs and in the design of innovative ones.
If it is necessary to go on talking about history, it is time to offer some information about Pharmaceuticals. In 1231 Roman Emperor Fredrick II separated the pharmaceutical profession from the medical profession and at that moment medication history changed. In 1546 the first organized list of substances and medical chemicals appeared in Germany and pharmaceutical science achieved an important objective toward a better organization. Past events can help people to know more about the medications they take and it may be a good way of trusting them. Which was the first human concern about health? The relief of pain has been one of the main reasons for expansion of Health Care and Pharmacology.
Tramadol history is worth telling because this active ingredient is contained in many products that help to relieve pain and this fact is very important for suffering patients.
Once upon a time there was a big pharmaceutical company that decided to fight against pain that was being suffered by millions of patients all over the world. That big corporation is Grünenthal GmbH.
Grünenthal GmbH was founded in 1946 in German and it has been owned by a family (The Wirtz) since then. Their first objective was to produce medicines for the penniless German inhabitants after the Second World War. To manufacture their products they used medicinal herbs they cultivated on their leased land. In 1948, the company experienced an important event; Grünenthal brought the first penicillin medication on the market.
Grünenthal enlarged its product range by cooperation with other pharmaceutical companies and by performing its own researches. In 1962 Tramadol was born and Tramal® development started. After 15 years of uninterrupted investigation, Tramal® (Tramadol) was launched in 1977. This molecule revolutionized the painkiller market because it is different from other opioids, it has a double mode of action.
Grünenthal young Executive Board follows Wirtz family tradition but their modern vision about pharmaceutical business has improved the company in many aspects. They are eager to put a new philosophy for managers and employees. They want Grünenthal become a synonym of reliability, modernity, concern and professionalism.
The company is not alone in the struggle against disease. Grünenthal GmbH has signed licensing agreements with other companies (like Ortho-McNeil Pharmaceutical and Takeda) to research and develop high quality medicines and commercializes them in many countries.
This is only a part of the story. After the first Tramadol release, other companies started to market this drug with a wide range of brand names and different pharmaceutical forms.
The latest pharmaceutical news says that once-daily Tramadol was launched in Korea and Australia. It means that Tramadol has been also changed during the last 20 years. It has been improved to offer patients faster and better pain relief. Tramadol future will depend on how doctors and patients will use it and how pharmaceutical companies will improve this drug substance to make it the best in its category.
Tramadol has an important scientific background that enables this drug substance to help millions of patients all around the world and there is a family behind this active principle. Their major concerns are helping people who need medical support.
Life and health are precious treasures that people must take care of. Grünenthal GmbH has protected them since its foundation. For the company, science is the tool to improve people quality of life.
This history has been focused on the development of a pharmaceutical product. And it is not only associated with past; it is also the future of human health. Tramadol history does not have an end and this is a good thing.
Tramadol history is worth telling because this active ingredient is contained in many products that help to relieve pain and this fact is very important for suffering patients.
Once upon a time there was a big pharmaceutical company that decided to fight against pain that was being suffered by millions of patients all over the world. That big corporation is Grünenthal GmbH.
Grünenthal GmbH was founded in 1946 in German and it has been owned by a family (The Wirtz) since then. Their first objective was to produce medicines for the penniless German inhabitants after the Second World War. To manufacture their products they used medicinal herbs they cultivated on their leased land. In 1948, the company experienced an important event; Grünenthal brought the first penicillin medication on the market.
Grünenthal enlarged its product range by cooperation with other pharmaceutical companies and by performing its own researches. In 1962 Tramadol was born and Tramal® development started. After 15 years of uninterrupted investigation, Tramal® (Tramadol) was launched in 1977. This molecule revolutionized the painkiller market because it is different from other opioids, it has a double mode of action.
Grünenthal young Executive Board follows Wirtz family tradition but their modern vision about pharmaceutical business has improved the company in many aspects. They are eager to put a new philosophy for managers and employees. They want Grünenthal become a synonym of reliability, modernity, concern and professionalism.
The company is not alone in the struggle against disease. Grünenthal GmbH has signed licensing agreements with other companies (like Ortho-McNeil Pharmaceutical and Takeda) to research and develop high quality medicines and commercializes them in many countries.
This is only a part of the story. After the first Tramadol release, other companies started to market this drug with a wide range of brand names and different pharmaceutical forms.
The latest pharmaceutical news says that once-daily Tramadol was launched in Korea and Australia. It means that Tramadol has been also changed during the last 20 years. It has been improved to offer patients faster and better pain relief. Tramadol future will depend on how doctors and patients will use it and how pharmaceutical companies will improve this drug substance to make it the best in its category.
Tramadol has an important scientific background that enables this drug substance to help millions of patients all around the world and there is a family behind this active principle. Their major concerns are helping people who need medical support.
Life and health are precious treasures that people must take care of. Grünenthal GmbH has protected them since its foundation. For the company, science is the tool to improve people quality of life.
This history has been focused on the development of a pharmaceutical product. And it is not only associated with past; it is also the future of human health. Tramadol history does not have an end and this is a good thing.
No comments:
Post a Comment